You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Transfusion dependent

Showing 26 - 50 of 5,970
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Thalassemia Trial in Peshawar (Thalidomide and Hydroxyurea)

Completed
  • Thalassemia
  • Thalidomide and Hydroxyurea
  • Peshawar, Khyber Pakhtukhwa, Pakistan
    Blood Diseases Clinic
Mar 10, 2022

Transfusion Dependent Beta-thalassemia Trial in United States (ST-400 Investigational product)

Active, not recruiting
  • Transfusion Dependent Beta-thalassemia
  • ST-400 Investigational product
  • Los Angeles, California
  • +5 more
Jul 6, 2022

Beta-Thalassemia, Thalassemia, Genetic Diseases, Inborn Trial in Nashville (CTX001)

Recruiting
  • Beta-Thalassemia
  • +4 more
  • CTX001
  • Nashville, Tennessee
  • +5 more
Feb 2, 2023

Transfusion Dependent Beta-Thalassaemia Trial in Tianjin (ET-01)

Active, not recruiting
  • Transfusion Dependent Beta-Thalassaemia
  • ET-01
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Dec 9, 2021

Prospective Study on Feto-maternal outcoMe In aNemIc womEn

Active, not recruiting
  • Anemia
  • +6 more
  • iron deficiency, coagulation abnormalities
  • San Giovanni Rotondo, Foggia, Italy
  • +1 more
Feb 20, 2023

Beta-Thalassemia, Thalassemia, Hematologic Diseases Trial (CTX001)

Not yet recruiting
  • Beta-Thalassemia
  • +6 more
  • CTX001
  • (no location specified)
Jul 26, 2022

Myelodysplastic Syndrome Trial in New York (Revlimid (Lenalidomide))

Active, not recruiting
Has Results
  • Myelodysplastic Syndrome
  • Revlimid (Lenalidomide)
  • New York, New York
    Columbia University Medical Center
Jan 12, 2022

Beta-Thalassemia Trial in Bulgaria, Israel, United States (VIT-2763 60 mg QD, VIT-2763 60 mg BID, VIT-2763 120 mg BID)

Withdrawn
  • Beta-Thalassemia
  • VIT-2763 60 mg QD
  • +3 more
  • Whittier, California
  • +6 more
Nov 7, 2022

Aplastic Anemia, Drug Effect Trial in Beijing (Herombopag + CsA, rhTPO combined with Herombopag + CsA)

Not yet recruiting
  • Aplastic Anemia
  • Drug Effect
  • Herombopag + CsA
  • rhTPO combined with Herombopag + CsA
  • Beijing, China
    Peking union medical college hospital
Aug 16, 2023

After Ex-vivo Gene Therapy With BIVV003 in Severe Sickle Cell

Recruiting
  • Blood and Lymphatic Diseases
  • Detroit, Michigan
    Investigational Site Number :8400001
Jul 6, 2022

Beta-Thalassemia, Thalassemia, Genetic Diseases, Inborn Trial in Worldwide (CTX001)

Active, not recruiting
  • Beta-Thalassemia
  • +4 more
  • CTX001
  • Stanford, California
  • +11 more
Nov 30, 2022

Transfusion-dependent Anemia, Surgery, Anemia Trial in Germany (red blood cell transfusion trigger)

Recruiting
  • Transfusion-dependent Anemia
  • +2 more
  • red blood cell transfusion trigger
  • Aachen, Germany
  • +8 more
Mar 28, 2022

Thalassemia, Iron Overload Trial in Nanning (CN128 Tablets)

Active, not recruiting
  • Thalassemia
  • Iron Overload
  • CN128 Tablets
  • Nanning, Guangxi, China
    The First Affiliated Hospital Of Guangxi Medical University
Aug 3, 2022

Diamond Blackfan Anemia Trial in Manhasset (Sotatercept, Sotatercept with prednisone boost)

Terminated
Has Results
  • Diamond Blackfan Anemia
  • Manhasset, New York
    North Shore- LIJ campus of The Feinstein Institute for Medical R
Nov 22, 2021

MDS Trial in Worldwide (Talacotuzumab, Daratumumab)

Completed
Has Results
  • Myelodysplastic Syndromes
  • Saint Louis, Missouri
  • +20 more
Dec 28, 2022

Thalassemia, Iron Overload Trial in Oakland (Combo Chelation with Deferasirox (Exjade) and Deferoxamine (DFO))

Completed
Has Results
  • Thalassemia
  • Iron Overload
  • Combo Chelation with Deferasirox (Exjade) and Deferoxamine (DFO)
  • Oakland, California
    CHRCO
Jul 20, 2021

Beta-Thalassemia Trial in Worldwide (LentiGlobin BB305 Drug Product)

Active, not recruiting
  • Beta-Thalassemia
  • LentiGlobin BB305 Drug Product
  • Oakland, California
  • +8 more
Feb 4, 2022

Thalassemia Major Trial in Ferrara (Blood component A, Blood component B)

Completed
  • Thalassemia Major
  • Blood component A
  • Blood component B
  • Ferrara, Italy
    Day Hospital Thalassaemia and Haemoglobinopathies (DHTE)
Nov 11, 2021

Thalassemia Trial in Worldwide (Luspatercept, Placebo, Best Supportive Care (BSC))

Active, not recruiting
Has Results
  • Thalassemia
  • Los Angeles, California
  • +16 more
Aug 16, 2022

Thalassemia, Iron Overload Trial in Nanning (CN128 Tablets)

Recruiting
  • Thalassemia
  • Iron Overload
  • CN128 Tablets
  • Nanning, Guangxi, China
    The First Affiliated Hospital Of Guangxi Medical University
Aug 3, 2022

Complications Associated With Intraoperative Hypothermia.

Completed
  • Hypothermia
  • +3 more
  • Hipotermia/Normotermia
  • Madrid, Spain
    Hospital Universitario La Paz
Jan 21, 2022

MDS, Transfusion-dependent Anemia Trial in France (Transfusion)

Recruiting
  • Myelodysplastic Syndromes
  • Transfusion-dependent Anemia
  • Transfusion
  • Abbeville, France
  • +18 more
Apr 4, 2022

Sickle Cell Anemia, Beta-thalassemia Major, Diamond-blackfan Anemia Trial in Pittsburgh (CD3/CD19 depleted leukocytes, CD45RA

Recruiting
  • Sickle Cell Anemia
  • +2 more
  • CD3/CD19 depleted leukocytes
  • +6 more
  • Pittsburgh, Pennsylvania
    Children's Hospital of Pittsburgh of UPMC
May 4, 2022

Patients Having Hip or Knee Arthroplasty

Completed
  • Transfusion-dependent Anemia
    • Bangkok, Thailand
      Siriraj hospital
    Sep 20, 2021

    Transfusion-dependent Thalassemia, Non-transfusion-dependent Thalassemia Trial in Worldwide (Deferasirox dispersable tablet

    Completed
    Has Results
    • Transfusion-dependent Thalassemia
    • Non-transfusion-dependent Thalassemia
    • Deferasirox dispersable tablet (DT)
    • Deferasirox film coated tablet (FCT)
    • Alexandria, Egypt
    • +16 more
    Sep 6, 2021